Oxford Immunotec competitors

Oxford Immunotec Competitors include Thriva, OncoCyte, Immucor and Ignyta.
Add company...
Oxford Immunotec
Oxford Immunotec
Oxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology.
Thriva
Thriva
Thriva connects people with their body through finger prick blood tests.
OncoCyte
OncoCyte
OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
Immucor
Immucor
A global leader in transfusion and transplantation diagnostics.
Ignyta
Ignyta
Blazing a new future for cancer patients.
Founding Date
Founding Date
2001
Founding Date
2015
Founding Date
N/A
Founding Date
1982
Founding Date
2011
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Milton, GB HQ
Shanghai, CN
Kohoku Ward, JP
Marlborough, US
Locations
Greater London, GB HQ
Locations
Alameda, US HQ
Locations
Norcross, US HQ
Locations
San Diego, US HQ
Employees
Employees
4379% decrease
Employees
23
Employees
167% increase
Employees
963
Employees
N/A
Valuation ($)
Valuation ($)
395.7 m
Valuation ($)
N/A
Valuation ($)
69.5 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
189
Twitter followers
2.5 k
Twitter followers
N/A
Twitter followers
160
Twitter followers
674

Financial

Revenue (est.)
Revenue (est.)
£77.6m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$380m (FY, 2016)
Revenue (est.)
N/A
Cost of goods
Cost of goods
£35.2m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$144m (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
£42.4m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$236m (FY, 2016)
Gross profit
N/A
Net income
Net income
(£25.8m) (FY, 2017)
Net income
N/A
Net income
($19.4m) (FY, 2017)
Net income
($43.8m) (FY, 2016)
Net income
($103.6m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 106.6m
Total funding raised
$ 1.9m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Thriva
HQ
Greater London, GB
Employees
23

Thriva connects people with their body through finger prick blood tests.

View company
OncoCyte
HQ
Alameda, US
Employees
16↑ 7% increase

OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

View company
Immucor
HQ
Norcross, US
Employees
963

A global leader in transfusion and transplantation diagnostics.

View company
Ignyta
HQ
San Diego, US

Blazing a new future for cancer patients.

View company